LATEST

• BUSINESS Sawai Pharmaceutical to Promote Toshiomi Nakate to President
  March 6, 2026

• BUSINESS Asahi Kasei Pharma to Rebrand as Asahi Kasei Therapeutics in April
  March 6, 2026

• BUSINESS Keytruda Maintains Top Spot for 29 Straight Months in February: Encise
  March 6, 2026

• REGULATORY Japan Drug Prices to Fall 4% in FY2026 Revision: Official Gazette
  March 5, 2026

• REGULATORY Romiplate to See Steepest Cut in April Market Expansion Re-Pricing
  March 5, 2026

• BUSINESS Takeda Files Japan NDA for Narcolepsy Drug Oveporexton
  March 5, 2026

• BUSINESS Kyowa Kirin Sticks to Long-Term Targets despite Rocatinlimab Setback
  March 5, 2026

• REGULATORY MHLW Clarifies Use of Real-World Data in Drug Applications
  March 5, 2026

• REGULATORY MHLW Expands Eligibility for “Specific-Use Drug” Designation
  March 5, 2026

• REGULATORY MHLW to Launch Priority Review Pathway for Overseas Alternatives amid Drug Shortages
  March 5, 2026

• REGULATORY LDP Health Panel Approves Health Insurance Bill with OTC-Like Drug Charges
  March 5, 2026

• BUSINESS Ono Partners with Congruence on Neurology, Immunology Drug Discovery
  March 5, 2026

• BUSINESS Nxera Files for Daridorexant Approval in South Korea
  March 5, 2026

• BUSINESS Sawai Prevails in Patent Suit against Viatris over Amitiza Generic
  March 5, 2026

• BUSINESS Kyowa Kirin Halts Rocatinlimab Clinical Trials on Malignancy Concerns
  March 4, 2026

• BUSINESS Meiji’s Morcamilast Wins EU Orphan Tag for Palmoplantar Pustulosis
  March 4, 2026

• BUSINESS Efient AGs Launched Just Ahead of 3-Month Supply Deadline
  March 4, 2026

• BUSINESS Takeda Targets Psoriasis Market with Zasocitinib, Touts Edge in TYK2 Selectivity
  March 4, 2026

• BUSINESS Sumitomo Regains Growth Momentum, Eyes 350 Billion Yen from 2 Key Drugs in FY2028
  March 3, 2026

• REGULATORY Japan Panel Backs Daiichi’s MMR Vaccine, Haihe’s PI3Kα Inhibitor, MSD’s HIV Med
  March 3, 2026

ページ

• « 先頭
• ‹ Prev
• …
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• …
• Next ›
• 最終 »